The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
How long does a hip replacement last?
February 15th 2019Total hip replacements are one of the most common and effective surgeries for women and men with osteoarthritis. The surgery can work miracles in patients, but the technology behind the surgery is not indestructible. At what point does failure set in?
Study Upends Pro Fish Consumption Theory in Rheumatoid Arthritis
February 12th 2019Despite years of research that show omega-3 fatty acids from specific fish species can improve rheumatoid arthritis (RA) symptoms and even protect at-risk patients from developing RA, a new study of 3,863,909 person-years published in BMC Musculoskeletal Disorders finds no benefit.
Calprotectin Test Predicts Relapse in RA and PsA
February 12th 2019Calprotectin is a known marker of disease activity in rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Now, researchers reporting in Arthritis Research and Therapy say that baseline calprotectin levels may predict disease relapse for RA and PsA patients on TNFi therapy. Learn more in this slideshow.
From Mild to Serious, Common to Rare: The Adverse Events of Osteoporosis Drugs
February 4th 2019A market analysis shows that bisphosphonates will reach $14 billion in sales by 2021. As more patients are prescribed these osteoporosis drugs, physicians will increasingly be faced with managing drug-related adverse events. Learn more in this article.
Less is More for TNFi Dosing in Axial Spondyloarthritis
February 4th 2019Researchers writing in Arthritis Research and Therapy describe the results of a randomized clincal trial in which most patients with Ankylosing spondylitis maintained low disease activity or remission with standard or reduced TNFi dose schedules.
Abnormal Nail Folds may Suggest Abnormal Pulmonary Function
February 1st 2019Abnormal nail folds with a pattern indicating systemic sclerosis (SSc) is common in patients with Raynaud's syndrome, shows a study recently published in the Journal of Rheumatology. It can also be present in patients with other forms of connective tissue disease, such as primary Sjögren syndrome, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease. An SSc abnormal nail growth pattern was also found to be associated with abnormal pulmonary function tests (PFT). Learn more here in this slideshow.
Opioid Use Common Before Surgery, Raises Risks of Adverse Events
February 1st 2019"Nearly one-third of pre‐surgical osteoarthritis patients used prescription opioid medication. Given the questionable efficacy of opioids in OA and risk of adverse effects, higher opioid use among younger individuals and those with depressive symptoms is of concern and warrants further investigation," researchers write in the January 10 issue of Arthritis Care and Research.
Updated Psoriatic Arthritis Treatment Guidelines Emphasize Treat-to-Target
January 29th 2019New joint guidelines by the American College of Rheumatology and National Psoriasis Foundation recommend psoriatic arthritis patients receive a treat-to-target approach, first-line use of tumor necrosis factor inhibitors biologics, and smoking cessation.